This result is in alignment with the observations reported by Weichert et al. [20], who present an increased expression of HDAC-2 in serous carcinomas compared with endometrioid carcinomas, the latter showing the lowest expression levels among all histological types. The gene discussed is HDAC2; the disease is serous adenocarcinoma.